The hidden epidemic of chronic wounds in Australia will be tackled through new initiatives funded with more than $3 mill...
Novartis is investing $256 million to expand its biopharmaceutical manufacturing plant in Singapore. The extended s...
Scientists from Duke-NUS Medical School (Duke-NUS) at Singapore have developed a new approach using the Zika virus to de...
Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...
Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...
In a breakthrough for personalised oncology, scientists from the National University of Singapore (NUS) and the National...
A collaborative research team from the Department of Chemical Engineering and the School of Convergence Science and Tech...
Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...
Orthohantaviruses, highly transmissible zoonotic pathogens, are notorious for causing haemorrhagic fever with renal synd...
As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earni...
Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...
China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...
The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...
Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...
A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...
According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...
The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...
Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...
